Total Payments
$24,888
2024 Payments
$1,602
Companies
46
Transactions
1,134
Medicare Patients
13,007
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$18,645 (74.9%)
Other$5,000 (20.1%)
Travel$1,215 (4.9%)
Education$28.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,645 | 1,127 | 74.9% |
| Grant | $5,000 | 1 | 20.1% |
| Travel and Lodging | $1,215 | 2 | 4.9% |
| Education | $28.99 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $5,332 | 5 | $0 (2019) |
| Boston Scientific Corporation | $3,973 | 95 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,583 | 202 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,396 | 76 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,288 | 44 | $0 (2020) |
| Medtronic, Inc. | $1,171 | 30 | $0 (2024) |
| Gilead Sciences, Inc. | $1,128 | 138 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $961.75 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $928.45 | 73 | $0 (2024) |
| Abbott Laboratories | $812.58 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,602 | 97 | Boehringer Ingelheim Pharmaceuticals, Inc. ($253.76) |
| 2023 | $2,328 | 150 | Medtronic, Inc. ($441.27) |
| 2022 | $2,379 | 173 | Boston Scientific Corporation ($351.94) |
| 2021 | $2,079 | 151 | Medtronic, Inc. ($384.47) |
| 2020 | $1,186 | 62 | AstraZeneca Pharmaceuticals LP ($303.65) |
| 2019 | $2,381 | 153 | Boston Scientific Corporation ($531.86) |
| 2018 | $9,386 | 177 | BIOTRONIK INC. ($5,000) |
| 2017 | $3,547 | 171 | BOSTON SCIENTIFIC CORPORATION ($676.36) |
All Payment Transactions
1,134 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Medtronic, Inc. | CROME DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $34.96 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 10/19/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $109.90 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.36 | General |
| 08/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,037 | 5,982 | $1.2M | $483,801 |
| 2022 | 22 | 3,434 | 6,522 | $1.3M | $550,646 |
| 2021 | 26 | 3,322 | 6,439 | $1.2M | $512,828 |
| 2020 | 28 | 3,214 | 5,691 | $1.1M | $464,684 |
Total Patients
13,007
Total Services
24,634
Medicare Billing
$2.0M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 340 | 1,315 | $131,500 | $89,326 | 67.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 208 | 209 | $207,600 | $79,858 | 38.5% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 87 | 90 | $90,000 | $69,331 | 77.0% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 206 | 621 | $124,200 | $47,326 | 38.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 253 | 253 | $101,200 | $41,488 | 41.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 161 | 162 | $56,700 | $26,240 | 46.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 135 | 544 | $81,600 | $23,487 | 28.8% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 106 | 106 | $31,800 | $21,904 | 68.9% |
| 78472 | Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | Office | 2023 | 94 | 95 | $47,500 | $17,563 | 37.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 344 | 1,193 | $95,440 | $13,252 | 13.9% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 242 | 302 | $30,200 | $10,171 | 33.7% |
| A9560 | Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries | Office | 2023 | 95 | 96 | $28,800 | $8,006 | 27.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 75 | 204 | $24,480 | $6,900 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $12,500 | $5,697 | 45.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 36 | 36 | $10,800 | $5,440 | 50.4% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 89 | 89 | $26,700 | $4,891 | 18.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 70 | 89 | $15,960 | $3,981 | 24.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 71 | 71 | $12,780 | $3,823 | 29.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 87 | 89 | $4,450 | $1,636 | 36.8% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 12 | 24 | $2,400 | $1,350 | 56.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 19 | 19 | $5,700 | $1,069 | 18.7% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 15 | 23 | $2,300 | $906.91 | 39.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 242 | 302 | $9,060 | $153.82 | 1.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 369 | 1,407 | $140,700 | $98,401 | 69.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 230 | 231 | $231,000 | $92,461 | 40.0% |
About Dr. Benjamin Camacho, M.D
Dr. Benjamin Camacho, M.D is a Cardiovascular Disease healthcare provider based in National City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699759936.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Camacho, M.D has received a total of $24,888 in payments from pharmaceutical and medical device companies, with $1,602 received in 2024. These payments were reported across 1,134 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($18,645).
As a Medicare-enrolled provider, Camacho has provided services to 13,007 Medicare beneficiaries, totaling 24,634 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Specialist
- Location National City, CA
- Active Since 11/30/2005
- Last Updated 01/30/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1699759936
Products in Payments
- WATCHMAN (Device) $2,873
- ENTRESTO (Drug) $1,430
- XARELTO (Drug) $1,141
- JARDIANCE (Drug) $928.45
- VERQUVO (Drug) $600.18
- MICRA (Device) $589.41
- LifeVest (Device) $513.96
- UPTRAVI (Drug) $467.55
- WATCHMAN Access System (Device) $462.08
- LOKELMA (Drug) $454.09
- Azure (Device) $445.40
- Kerendia (Drug) $428.51
- Micra (Device) $389.24
- EMBLEM (Device) $359.32
- ELIQUIS (Drug) $332.66
- BRILINTA (Drug) $331.76
- Claria MRI (Device) $328.11
- OPSUMIT (Drug) $292.57
- Amplia MRI (Device) $287.44
- INVOKANA (Drug) $255.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in National City
Albert Sharf, Md, MD
Cardiovascular Disease — Payments: $98,521
Cardiovascular Disease $98,521
Kambiz Shetabi, M.d, M.D
Cardiovascular Disease — Payments: $18,744
Cardiovascular Disease $18,744
Jerome Robinson, Md, MD
Cardiovascular Disease — Payments: $10,511
Cardiovascular Disease $10,511
Dr. Genaro Fernandez, Md, MD
Cardiovascular Disease — Payments: $8,071
Cardiovascular Disease $8,071
Jay Pandhi, Md, MD
Cardiovascular Disease — Payments: $2,271
Cardiovascular Disease $2,271